302 related articles for article (PubMed ID: 25955186)
1. A Systematic Review of Lumbar Fusion Rates With and Without the Use of rhBMP-2.
Galimberti F; Lubelski D; Healy AT; Wang T; Abdullah KG; Nowacki AS; Benzel EC; Mroz TE
Spine (Phila Pa 1976); 2015 Jul; 40(14):1132-9. PubMed ID: 25955186
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of anterior lumbar interbody fusion (ALIF) versus posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), posterolateral lumbar fusion (PLF).
Rathbone J; Rackham M; Nielsen D; Lee SM; Hing W; Riar S; Scott-Young M
Eur Spine J; 2023 Jun; 32(6):1911-1926. PubMed ID: 37071155
[TBL] [Abstract][Full Text] [Related]
3. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
4. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
5. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
[TBL] [Abstract][Full Text] [Related]
6. Posterolateral fusion with interbody for lumbar spondylolisthesis is associated with less repeat surgery than posterolateral fusion alone.
Macki M; Bydon M; Weingart R; Sciubba D; Wolinsky JP; Gokaslan ZL; Bydon A; Witham T
Clin Neurol Neurosurg; 2015 Nov; 138():117-23. PubMed ID: 26318363
[TBL] [Abstract][Full Text] [Related]
7. Off-label innovation: characterization through a case study of rhBMP-2 for spinal fusion.
Schnurman Z; Smith ML; Kondziolka D
J Neurosurg Spine; 2016 Sep; 25(3):406-14. PubMed ID: 27104282
[TBL] [Abstract][Full Text] [Related]
8. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
[TBL] [Abstract][Full Text] [Related]
9. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of clinical outcomes in surgical treatment of adult isthmic spondylolisthesis.
Noorian S; Sorensen K; Cho W
Spine J; 2018 Aug; 18(8):1441-1454. PubMed ID: 29746966
[TBL] [Abstract][Full Text] [Related]
11. rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres.
Vincentelli AF; Szadkowski M; Vardon D; Litrico S; Fuentès S; Steib JP; Le Huec JC; Huppert J; Dubois G; Lenoir T; Sailhan F; Passuti N
Orthop Traumatol Surg Res; 2019 Oct; 105(6):1157-1163. PubMed ID: 31324520
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of interbody fusions versus posterolateral fusions in 137 patients with lumbar spondylolisthesis.
Bydon M; Macki M; Abt NB; Witham TF; Wolinsky JP; Gokaslan ZL; Bydon A; Sciubba DM
Spine J; 2015 Mar; 15(3):492-8. PubMed ID: 25463402
[TBL] [Abstract][Full Text] [Related]
13. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis comparing ALIF, PLIF, TLIF and LLIF.
Teng I; Han J; Phan K; Mobbs R
J Clin Neurosci; 2017 Oct; 44():11-17. PubMed ID: 28676316
[TBL] [Abstract][Full Text] [Related]
15. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
16. Transforaminal lumbar interbody fusion (TLIF) versus posterior lumbar interbody fusion (PLIF) in lumbar spondylolisthesis: a systematic review and meta-analysis.
de Kunder SL; van Kuijk SMJ; Rijkers K; Caelers IJMH; van Hemert WLW; de Bie RA; van Santbrink H
Spine J; 2017 Nov; 17(11):1712-1721. PubMed ID: 28647584
[TBL] [Abstract][Full Text] [Related]
17. Single-level Posterolateral Fusion (PLF) Alone and Posterior Interbody Fusion (PLIF/TLIF) Alone Lead to a Decreased Risk of Short-term Complications Compared to Combined PLF With PLIF/TLIF Procedures: A Matched Analysis.
Plantz MA; Hsu WK
Spine (Phila Pa 1976); 2020 Nov; 45(21):E1391-E1399. PubMed ID: 32796465
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
19. Fusion techniques for adult isthmic spondylolisthesis: a systematic review.
Wang SJ; Han YC; Liu XM; Ma B; Zhao WD; Wu DS; Tan J
Arch Orthop Trauma Surg; 2014 Jun; 134(6):777-84. PubMed ID: 24715157
[TBL] [Abstract][Full Text] [Related]
20. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
Villavicencio AT; Burneikiene S
Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
